53 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2026-09-30 | Chia-Yang Lin | IND | Regeneron Pharmaceuticals Inc. | SVP - Immuno-Oncology | $384.60 |
| 2026-09-30 | Marion McCourt | IND | Regeneron Pharmaceuticals Inc. | EVP - Commercial | $384.60 |
| 2026-09-30 | Lori Morton | IND | Regeneron Pharmaceuticals Inc. | SVP - Research | $384.60 |
| 2026-09-30 | Andrew Murphy | IND | Regeneron Pharmaceuticals Inc. | EVP - Research | $384.60 |
| 2026-09-30 | Michele Crocco | IND | Regeneron Pharmaceuticals Inc. | VP - Human Resources | $384.60 |
| 2026-09-30 | William Olson | IND | Regeneron Pharmaceuticals Inc. | SVP - Therapeutic Proteins | $384.60 |
| 2026-09-30 | Mark Volpe | IND | Regeneron Pharmaceuticals Inc. | Senior Vice President - Tax | $384.60 |
| 2026-09-30 | David Crenshaw | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $384.60 |
| 2026-09-30 | Joseph LaRosa | IND | Regeneron Pharmaceuticals Inc. | EVP - General Counsel & Secretary | $384.60 |
| 2026-09-30 | Leonard Schleifer | IND | Regeneron Pharmaceuticals Inc. | President & CEO | $384.60 |
| 2026-09-30 | Zoran Berkovic | IND | Regeneron Pharmaceuticals Inc. | SVP - Financial Planning & Analysis | $384.60 |
| 2026-09-30 | John Ryan | IND | Regeneron Pharmaceuticals Inc. | VP - Global Rare Disease & CCBU | $384.60 |
| 2026-09-30 | Amrita Rahmani | IND | Regeneron Pharmaceuticals Inc. | VP - Corporate Strategy | $384.60 |
| 2026-09-30 | Kerry Reinertsen | IND | Regeneron Pharmaceuticals Inc. | SVP - Strategic Alliances | $384.60 |
| 2026-09-30 | Samuel Davis | IND | Regeneron Pharmaceuticals Inc. | VP - Discovery Technologies Research | $384.60 |
| 2026-09-30 | Brian Zambrowicz | IND | Regeneron Pharmaceuticals Inc. | EVP - Functional Genomics and Chief VG | $384.60 |
| 2026-09-30 | Aristides Economides | IND | Regeneron Pharmaceuticals Inc. | VP - Research | $384.60 |
| 2026-09-30 | Christine Enciso | IND | Regeneron Pharmaceuticals Inc. | VP - Dev Services & Op Excellence | $384.60 |
| 2026-09-30 | Dale Fanning | IND | Regeneron Pharmaceuticals Inc. | VP - Tax | $384.60 |
| 2026-09-30 | Christopher Fenimore | IND | Regeneron Pharmaceuticals Inc. | EVP - CFO | $384.60 |
| 2026-09-30 | Hanne Bak | IND | Regeneron Pharmaceuticals Inc. | SVP - PreClinical Manu. & Proc. Dev. | $384.60 |
| 2026-09-30 | Richard Gluckselig | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $384.60 |
| 2026-09-30 | Paige White | IND | Regeneron Pharmaceuticals Inc. | VP - Strategic Customer Engagement | $384.60 |
| 2026-09-30 | Philip Gregory | IND | Regeneron Pharmaceuticals Inc. | SVP - Head of Cell Medicines | $384.60 |
| 2026-09-30 | Rostislav Chernomorsky | IND | Regeneron Pharmaceuticals Inc. | VP R&PD Core Services | $384.60 |
| 2026-09-30 | Gary Herman | IND | Regeneron Pharmaceuticals Inc. | SVP - Clinical Dev. Unit Head | $384.60 |
| 2026-09-30 | Justin Holko | IND | Regeneron Pharmaceuticals Inc. | SVP - Global Oncology & Hematology CBU | $384.60 |
| 2026-09-30 | Larry Coury | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $384.60 |
| 2026-09-30 | Sally Paull | IND | Regeneron Pharmaceuticals Inc. | Executive VP - Human Resources | $384.00 |
| 2026-09-30 | Maya Bermingham | IND | Regeneron Pharmaceuticals Inc. | SVP - Gov. Affairs & Public Policy | $384.00 |
| 2026-09-30 | Ned Braunstein | IND | Regeneron Pharmaceuticals Inc. | EVP - Regulatory Affairs | $384.00 |
| 2026-09-30 | Fraley George | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $230.00 |
| 2026-09-30 | David Glass | IND | Regeneron Pharmaceuticals Inc. | VP - Research | $192.30 |
| 2026-09-30 | Ryan Crowe | IND | Regeneron Pharmaceuticals Inc. | SVP - Investor Relations | $192.30 |
| 2026-09-30 | Christopher Daly | IND | Regeneron Pharmaceuticals Inc. | VP - Oncology & Angiogenesis | $192.30 |
| 2026-09-30 | Madeleine Davidson | IND | Regeneron Pharmaceuticals Inc. | Director, Gvt. Affairs & Public Policy | $192.30 |
| 2026-09-30 | Eben DuRoss | IND | Regeneron Pharmaceuticals Inc. | Director, Govt Affairs & Public Policy | $192.30 |
| 2026-09-30 | Kimberly Greco | IND | Regeneron Pharmaceuticals Inc. | Executive Dir. of Gvt. Affairs | $192.30 |
| 2026-09-30 | Katherine Haddad | IND | Regeneron Pharmaceuticals Inc. | Sr. Dir., Gvt. Affairs & Public Policy | $192.30 |
| 2026-09-30 | Nisha Koria | IND | Regeneron Pharmaceuticals Inc. | Executive Director, Public Policy | $192.30 |
| 2026-09-30 | Timothy Landy | IND | Regeneron Pharmaceuticals Inc. | VP - Commercial | $192.30 |
| 2026-09-30 | Jessica Nagro | IND | Regeneron Pharmaceuticals Inc. | Director - Government Affairs | $192.30 |
| 2026-09-30 | Justin Pine | IND | Regeneron Pharmaceuticals Inc. | Director - Public Policy | $192.30 |
| 2026-09-30 | Kellie Taylor | IND | Regeneron Pharmaceuticals Inc. | VP - CMC Regulatory Affairs | $192.30 |
| 2026-09-30 | Albert Torri | IND | Regeneron Pharmaceuticals Inc. | VP - Bioanalytical Science | $192.30 |
| 2026-09-30 | Joanna Young | IND | Regeneron Pharmaceuticals Inc. | Sr. Dir., Gvt. Affairs & Public Policy | $160.00 |
| 2026-09-30 | Jason Pitofsky | IND | Regeneron Pharmaceuticals Inc. | SVP - Controller | $150.00 |
| 2026-09-30 | Gang Chen | IND | Regeneron Pharmaceuticals Inc. | SVP - Protein Expression Sciences | $100.00 |
| 2026-09-30 | Vera Mastey | IND | Regeneron Pharmaceuticals Inc. | VP - Health Econ & Outcomes Research | $76.92 |
| 2026-09-30 | Christina Chan | IND | Regeneron Pharmaceuticals Inc. | SVP - Corporate Affairs | $76.92 |
| 2026-09-30 | Alan Shuldiner | IND | Regeneron Pharmaceuticals Inc. | VP Regeneron Genetics Center | $76.92 |
| 2026-09-30 | Michelle LaFond | IND | Regeneron Pharmaceuticals Inc. | VP - Preclinical Manuf. & Process | $50.00 |
| 2026-09-04 | Regeneron Pharmaceuticals, Inc. | ORG | $520.68 |